钙敏感受体在骨肉瘤中的研究进展
Research progress of Calcium Sensing Receptors in Osteosarcoma
DOI: 10.12677/ACM.2023.1351079, PDF,   
作者: 刘 瑶, 赵 勇*：佳木斯大学基础医学院，黑龙江 佳木斯；黑龙江省微生态–免疫调节网络与相关疾病重点实验室，黑龙江 佳木斯
关键词: 骨肉瘤；钙敏感受体；成骨细胞；破骨细胞；Osteosarcoma； Calcium Sensing Receptor； Osteoblasts； Osteoclasts
摘要: 骨肉瘤(osteosarcoma, OS)是来源于间充质的恶性骨肿瘤，常侵犯长骨的干骺端，特别是股骨远端和胫骨近端，并易于血行肺转移。随着新辅助化疗的进步，OS患者5年内生存率虽然有所改善，但其远期治疗效果仍不理想，复发转移是OS治疗失败的重要原因。钙敏感受体(CaSR)属于G蛋白耦联受体家族成员，在维持钙离子和细胞内稳态，以及调节多种细胞增殖、分化、细胞凋亡和激素分泌等方面发挥重要作用。CaSR可通过激活或抑制机制为OS的治疗提供新的途径。
Abstract: Osteosarcoma (OS) is a malignant bone tumor originating in the mesenchyme, which frequently damages the metaphysis of long bones, especially in the distal femur and proximal tibia, but also predisposes to blood to lung metastasis. Although patients’ survival has improved in all five years with the advance of neoadjuvant chemotherapy technology, the long-term outcome is unsatisfacto-ry. Because calcium-sensing receptor (CaSR) is an important component of G-protein-coupled re-ceptors, it plays a pivotal role in protecting cells from calcium ions, cell stability, cell growth, differ-entiation, apoptosis, and hormone production. CaSR will open a whole new road to the development of OS, whether by activating or inhibiting mechanisms.
文章引用：刘瑶, 赵勇. 钙敏感受体在骨肉瘤中的研究进展[J]. 临床医学进展, 2023, 13(5): 7723-7728. https://doi.org/10.12677/ACM.2023.1351079

参考文献

[1] Eaton, B.R., Schwarz, R., Vatner, R., et al. (2021) Osteosarcoma. Pediatric Blood & Cancer, 68, e28352.
[2] Hofer, A.M. and Brown, E.M. (2003) Extracellular Calcium Sensing and Signalling. Nature Reviews Molecular Cell Biology, 4, 530-538. [Google Scholar] [CrossRef] [PubMed]
[3] 郑家强, 杨建虹. 骨相关细胞中钙敏感受体研究进展[J]. 中国骨质疏松杂志, 2009, 15(9): 685-688.
[4] Saraf, A.J., Fenger, J.M. and Roberts, R.D. (2018) Osteosarcoma: Acceler-ating Progress Makes for a Hopeful Future. Frontiers in Oncology, 8, Article 4. [Google Scholar] [CrossRef] [PubMed]
[5] 郭伟, 张志愿. 口腔颌面部肿瘤基因治疗的进展[J]. 口腔颌面外科杂志, 2001(S1): 4-6.
[6] Song, S.U. and Boyce, F.M. (2001) Combination Treatment for Osteosarcoma with Bacu-loviral Vector Mediated Gene Therapy (p53) and Chemotherapy (Adriamycin). Experimental & Molecular Medicine, 33, 46-53. [Google Scholar] [CrossRef] [PubMed]
[7] Densmore, C.L., Kleinerman, E.S., Gautam, A., et al. (2001) Growth Suppression of Established Humanosteosarcoma Lung Metastases in Mice by Aerosol Gene Therapy with PEI-p53 Complexes. Cancer Gene Therapy, 8, 619-627. [Google Scholar] [CrossRef] [PubMed]
[8] Benjamin, R., Helman, L., Meyers, P., et al. (2001) A Phase I/II Dose Escalation and Activity Study of Intravenous Injections of OCaP1 for Subjects with Refractory Osteosarcoma Metastatic to Lung. Human Gene Therapy, 12, 1591-1593.
[9] Walling, H.W., Swarthout, J.T. and Culver, K.W. (2000) By-stander-Mediated Regression of Osteosarcoma via Retroviral Transfer of the Herpes Simplex Virus Thymidine Kinase and Human Interleukin-2 Genes. Cancer Gene Therapy, 7, 187-196. [Google Scholar] [CrossRef] [PubMed]
[10] Lafleur, E.A., Jia, S.F., Worth, L.L., et al. (2001) Interleukin (IL)-12 and IL-12 Gene Transfer Up-Regulate Fas Expression in Human Osteosarcoma and Breast Cancer Cells. Cancer Re-search, 61, 4066-4071.
[11] Zhou, M.Y., Cheng, L., Chen, L., Gu, Y.J. and Wang, Y. (2021) Calcium-Sensing Recep-tor in the Development and Treatment of Pulmonary Hypertension. Molecular Biology Reports, 48, 975-981. [Google Scholar] [CrossRef] [PubMed]
[12] Gorvin, C.M. (2019) Molecular and Clinical Insights from Stud-ies of Calcium-Sensing Receptor Mutations. Journal of Molecular Endocrinology, 63, R1-R16. [Google Scholar] [CrossRef] 
[13] Chavez-Abiega, S., Mos, I., Centeno, P.P., et al. (2020) Sensing Extra-cellular Calcium—An Insight into the Structure and Function of the Calcium-Sensing Receptor (CaSR). Advances in Ex-perimental Medicine and Biology, 1131, 1031-1063. [Google Scholar] [CrossRef] [PubMed]
[14] 黄章鑫, 张梁, 郭雨桐, 等. 钙敏感受体在高血压中的研究进展[J]. 中国现代医学杂志, 2022, 32(8): 58-63.
[15] Leach, K., Hannan, F.M., Josephs, T.M., et al. (2020) International Union of Basic and Clinical Pharmacology. CVIII. Calci-um-Sensing Receptor Nomenclature, Pharmacology, and Function. Pharmacological Reviews, 72, 558-604. [Google Scholar] [CrossRef] [PubMed]
[16] Xie, R., Tang, B., Yong, X., Luo, G. and Yang, S.M. (2014) Roles of the Calcium Sensing Receptor in Digestive Physiology and Pathophysiology (Review). International Journal of Oncolo-gy, 45, 1355-1362. [Google Scholar] [CrossRef] [PubMed]
[17] Ren, Z.Q., Yang, K., Zhao, M., et al. (2020) Calcium-Sensing Receptor on Neutrophil Promotes Myocardial Apoptosis and Fibrosis after Acute Myocardial Infarction via NLRP3 Inflam-masome Activation. Canadian Journal of Cardiology, 36, 893-905. [Google Scholar] [CrossRef] [PubMed]
[18] Canton, J., Schlam, D., Breuer, C., et al. (2016) Calcium-Sensing Receptors Signal Constitutive Macropinocytosis and Facilitate the Uptake of NOD2 Ligands in Macrophages. Nature Communications, 7, Article No. 11284. [Google Scholar] [CrossRef] [PubMed]
[19] Yamaguchi, T. and Sugimoto, T. (2007) Impaired Bone Mineralization in Calcium-Sensing Receptor (CaSR) Knockout Mice: The Physiological Action of CaSR in Bone Microenvironments. Clinical Calcium, 17, 1567-1573. (In Japanese)
[20] Chang, W., Tu, C., Chen, T.H., Bikle, D. and Shoback, D. (2008) The Extracellular Calcium-Sensing Receptor (CaSR) Is a Critical Modulator of Skeletal Development. Science Signaling, 1, ra1. [Google Scholar] [CrossRef] [PubMed]
[21] Chattopadhyay, N., Yano, S., Tfelt-Hansen, J., et al. (2004) Mitogenic Action of Calcium-Sensing Receptor on Rat Calvarial Osteoblasts. Endocrinology, 145, 3451-3462. [Google Scholar] [CrossRef] [PubMed]
[22] Ahlstrom, M., Pekkinen, M., Riehle, U. and Lamberg-Allardt, C. (2008) Extracellular Calcium Regulates Parathyroid Hormone-Related Peptide Expression in Osteoblasts and Osteoblast Progen-itor Cells. Bone, 42, 483-490. [Google Scholar] [CrossRef] [PubMed]
[23] Caverzasio, J. (2008) Strontium Ranelate Promotes Osteoblastic Cell Replication through at Least Two Different Mechanisms. Bone, 42, 1131-1136. [Google Scholar] [CrossRef] [PubMed]
[24] Dvorak-Ewell, M.M., Chen, T.H., Liang, N., et al. (2011) Osteo-blast Extracellular Ca2+-Sensing Receptor Regulates Bone Development, Mineralization, and Turnover. Journal of Bone and Mineral Research, 26, 2935-2947. [Google Scholar] [CrossRef] [PubMed]
[25] Okada, H., Okabe, K. and Tanaka, S. (2020) Finely-Tuned Calcium Oscilla-tions in Osteoclast Differentiation and Bone Resorption. International Journal of Molecular Sciences, 22, Article 180. [Google Scholar] [CrossRef] [PubMed]
[26] Kameda, T., Mano, H., Yamada, Y., et al. (1998) Calcium-Sensing Re-ceptor in Mature Osteoclasts, Which Are Bone Resorbing Cells. Biochemical and Biophysical Research Communications, 245, 419-422. [Google Scholar] [CrossRef] [PubMed]
[27] Cao, Y., Zhou, Z., de Crombrugghe, B., et al. (2005) Osterix, a Tran-scription Factor for Osteoblast Differentiation, Mediates Antitumor Activity in Murine Osteosarcoma. Cancer Research, 65, 1124-1128. [Google Scholar] [CrossRef] 
[28] Patanè, S., Avnet, S., Coltella, N., et al. (20006) MET Overexpression Turns Human Primary Osteoblasts into Osteosarcomas. Cancer Research, 66, 4750-4757. [Google Scholar] [CrossRef] 
[29] Czekanska, E.M., Stoddart, M.J., Richards, R.G. and Hayes, J.S. (2012) In Search of an Osteoblast Cell Model for in vitro Research. European Cells and Materials, 24, 1-17. [Google Scholar] [CrossRef] 
[30] Yang, G., Sun, X. and Wang, R. (2004) Hydrogen Sulfide-Induced Apoptosis of Human Aorta Smooth Muscle Cells via the Activation of Mitogen-Activated Protein Kinases and Caspase-3. The FASEB Journal, 18, 1782-1784. [Google Scholar] [CrossRef] [PubMed]
[31] Bai, S.Z., Sun, J., Wu, H., et al. (2012) Decrease in Calcium-Sensing Receptor in the Progress of Diabetic Cardiomyopathy. Diabetes Research and Clinical Practice, 95, 378-385. [Google Scholar] [CrossRef] [PubMed]
[32] Lagos-Cabré, R., Brenet, M., Díaz, J., et al. (2018) Intracellular Ca2+ Increases and Connexin 43 Hemichannel Opening Are Necessary But Not Sufficient for Thy-1-Induced Astrocyte Migration. International Journal of Molecular Sciences, 19, Article 2179. [Google Scholar] [CrossRef] [PubMed]
[33] Whelan, J., McTiernan, A., Cooper, N., et al. (2012) Incidence and Survival of Malignant Bone Sarcomas in England 1979-2007. International Journal of Cancer, 131, E508-E517. [Google Scholar] [CrossRef] [PubMed]
[34] Zhao, W., Zhang, Z., Zheng, L., et al. (2020) Calcium-Sensing Receptor Ac-tivating ERK1/2 and PI3K-Akt Pathways to Induce the Proliferation of Osteosarcoma Cells. Clinical and Experimental Pharmacology and Physiology, 47, 517-519. [Google Scholar] [CrossRef] [PubMed]
[35] Yan, M., Ni, J., Song, D., et al. (2015) Activation of Unfolded Protein Response Protects Osteosarcoma Cells from Cisplatin-Induced Apopto-sis through NF-κB Pathway. International Journal of Clinical and Experimental Pathology, 8, 10204-10215.
[36] Peng, L., Liu, A., Shen, Y., et al. (2013) Antitumor and Anti-Angiogenesis Effects of Thymoquinone on Osteosarcoma through the NF-κB Pathway. Oncology Reports, 29, 571-578. [Google Scholar] [CrossRef] [PubMed]
[37] Zheng, W.H., Feng, Z.H., You, S.B., et al. (2017) Fisetin Inhibits IL-1β-Induced Inflammatory Response in Human Osteoarthri-tis Chondrocytes through Activating SIRT1 and Attenuates the Progression of Osteoarthritis in Mice. International Im-munopharmacology, 45, 135-147. [Google Scholar] [CrossRef] [PubMed]
[38] 陈谱, 阮安民, 周俊, 等. 基于NF-κB信号通路探讨芍药苷对LPS诱导的人软骨细胞炎症及退变的作用机制[J]. 北京中医药大学学报, 2020, 43(11): 903-909.

为你推荐